Skip to content

Imx Havab

by Abbott Laboratories PMA

Active United States

PMA P780012

Overview

The IMX HAVAB is a diagnostic in vitro device classified as a Hepatitis A Test (Antibody and IgM Antibody), designed to detect antibodies and IgM antibodies to the Hepatitis A virus in human serum or plasma. It is intended for use in microbiology laboratories to aid in the diagnosis of Hepatitis A infection by identifying immune responses to the virus.

The IMX HAVAB is supplied as a reagent kit for use with the IMx system, a fully automated immunoassay analyzer. It is intended for single-use and requires no special storage conditions beyond those specified in the accompanying instructions. The device holds an FDA Premarket Approval (PMA) under PMA number P780012, with regulatory compliance under 21 CFR 866.3310. Authorized use is restricted to qualified laboratories and healthcare settings equipped with the IMx system.

AI-generated from registry data, 18 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved 1 supplement NumberP780012 Date25 Jun 1982ApprovedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA PMA Active

Recalls

1 recall · FDA

    • Terminated Z-1039-2007 FDA Unclassified (pre-2012) initiated 23 Apr 2007

    Failure of the AxSYM instrument to open (actuate) some reagent packs from certain lots. The defects can result in probe crashes if not detected prior to placement of the reagent kit on the AxYM instrument.

Specification

PMA

Trade Name
Havab
Generic Name
Hepatitis a test (antibody and igm antibody)
PMA Number
FDA Product Code
LOL
Device Class
Class II
Regulation
21 CFR Part 866.3310
Advisory Committee
Microbiology
FDA Decision
APPR Approved
PMA Supplement
S004

Other devices from Abbott Laboratories

See all devices from Abbott Laboratories →

Questions

  • What is the primary purpose of the IMX HAVAB device in a clinical setting?

    The IMX HAVAB is designed to detect antibodies and IgM antibodies to the Hepatitis A virus in human serum or plasma. This helps microbiology laboratories identify immune responses to Hepatitis A infection, aiding in the diagnosis of the disease.

  • How is the IMX HAVAB supplied and what system does it require for use?

    The IMX HAVAB is supplied as a reagent kit specifically for use with the IMx system, a fully automated immunoassay analyzer. It is not a standalone device and must be paired with this analyzer to function.

  • Is the IMX HAVAB intended for single-use or repeated use, and what storage requirements apply?

    The IMX HAVAB is intended for single-use only. While it does not require special storage conditions beyond those outlined in its instructions, standard laboratory practices for reagent storage should be followed to maintain its integrity.

  • What regulatory approval does the IMX HAVAB hold, and where is it authorized for use?

    The IMX HAVAB holds an FDA Premarket Approval (PMA) under PMA number P780012, with regulatory compliance under 21 CFR 866.3310. Its use is authorized exclusively for qualified microbiology laboratories and healthcare settings equipped with the IMx system.

  • Are there different sizes or models of the IMX HAVAB, or is it a single standardized test kit?

    The IMX HAVAB is described as a single reagent kit for the IMx system, with no mention of multiple sizes or models in the provided data. It is a standardized test designed for consistent use across compatible systems.